Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Gilead Sciences secures landmark US FDA clearance for rare and fatal liver infection

23/05/2026 Published by vivi

Biopharmaceutical multinational Gilead Sciences has announced that its investigational formulation targeting a rare and severe liver infection has officially secured... Read more

Tags: #Global Trends

Gilead Sciences expands oncology portfolio via $5 billion acquisition of Tubulis

22/05/2026 Published by vivi

Biopharmaceutical multinational Gilead Sciences has finalized the corporate acquisition of Tubulis GmbH, a privately held, Germany-based biotech entity operating at... Read more

Category: Uncategorized

Tags: #M&A

Moderna and Merck cancer combination demonstrates long-term efficacy in advanced melanoma

22/05/2026 Published by vivi

A combined therapeutic regimen engineered by Moderna and Merck & Co. has demonstrated significant long-term clinical efficacy, reducing the risk... Read more

Category: Uncategorized

Tags: #Global Trends

FDA schedules expert advisory assembly to evaluate Moderna’s mRNA-based influenza vaccine

22/05/2026 Published by vivi

The U.S. Food and Drug Administration (FDA) has announced plans to convene a panel of independent external experts next month... Read more

Category: Uncategorized

Tags: #Global Trends

Lower-priced oral formulations from Novo Nordisk and Eli Lilly trigger patient shift away from compounded alternatives

22/05/2026 Published by vivi

A competitive pricing strategy implemented for oral obesity medications developed by Novo Nordisk and Eli Lilly is altering the U.S.... Read more

Category: Uncategorized

Tags: #Global Trends

Gilead Sciences expands WHO alliance to donate 400,000 drug doses targeting deadly parasitic disease

22/05/2026 Published by vivi

Biopharmaceutical multinational Gilead Sciences and the World Health Organization (WHO) have formalized an expanded global health covenant aimed at eliminating... Read more

Category: Uncategorized

Tags: #Global Trends

Merck & Co. and Kelun advance frontline lung cancer landscape with TROP2 ADC combination

22/05/2026 Published by vivi

At the ASCO 2026 annual meeting, a comprehensive clinical update from the alliance between Merck & Co. and Kelun-Biotech has... Read more

Category: Uncategorized

Tags: #Global Trends

Hanoi Department of Health enforces recall on Sanco brain supplement over vitamin deficit

22/05/2026 Published by vivi

Under the statutory mandate of Decision No. 1639/QĐ-SYT, the municipal health authority of Hanoi has ordered an immediate marketplace recall... Read more

Category: Uncategorized

Tags: #Vietnam